{
    "2019-02-11": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：蓄力待发展望长期机遇",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "行业周报",
                        "长期机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药企并购热潮持续 医药行业大洗牌",
                "features": {
                    "keywords": [
                        "药企",
                        "并购",
                        "热潮",
                        "医药行业",
                        "洗牌"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "联讯证券：美年健康买入评级",
                "features": {
                    "keywords": [
                        "联讯证券",
                        "美年健康",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-02-10",
                "original_text": "【医药】江琦、王超（研究助理）：2月月报：信心正逐步恢复、Q1建议关注创新药、原料药和商业板块-20190210",
                "features": {
                    "keywords": [
                        "医药",
                        "月报",
                        "信心恢复",
                        "创新药",
                        "原料药",
                        "商业板块",
                        "Q1建议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新药",
                        "原料药",
                        "商业板块"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}